Richard D. Gill

Richard D. Gill

Directeur/Bestuurslid bij
Cognoptix, Inc.
Commercial Services
Finance
Health Technology

Profiel

Richard D.
Gill
currently works at Cognoptix, Inc., as Director and Lovelace Respiratory Research Institute, as Director.
Dr. Gill also formerly worked at Sierra Oncology, Inc., as President & Chief Executive Officer, TruTouch Technologies, Inc., as President, Chief Executive Officer & Director from 2011 to 2013, BioLegend CNS, Inc., as President & Chief Executive Officer, ActiveCyte, Inc., as President & Chief Executive Officer, AnVil, Inc., as President & Chief Executive Officer, SynDevRx, Inc., as Director, NABsys, Inc., as Director, Launchpad Venture Group LLC, as Director, Era Biotech SA, as Director, Oscient Pharmaceuticals Corp., as President & Chief Operating Officer, Unilever Plc, as Principal, BTG International, Inc., as Senior Vice President & General Manager, and Rittenhouse Ventures LLC, as Advisor.
Dr. Gill received his undergraduate degree and doctorate degree from The University of Reading.

Actieve functies van Richard D. Gill

BedrijvenFunctieBegin
Directeur/Bestuurslid -
Directeur/Bestuurslid -

Eerdere bekende functies van Richard D. Gill

BedrijvenFunctieEinde
Private Equity Investor 30-04-2008
Directeur/Bestuurslid -
Directeur/Bestuurslid -
UNILEVER PLC Corporate Officer/Principal -
President -
Ervaring van Richard D. Gill in detail bekijken

Opleiding van Richard D. Gill

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Connecties

17

Eerstegraads connecties

16

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Verwante bedrijven

Bedrijven in privébezit16

Commercial Services

Consumer Non-Durables

Health Technology

Health Services

Commercial Services

Commercial Services

Consumer Services

Finance

Health Technology

Commercial Services

Commercial Services

Finance

Finance

ActiveCyte, Inc.

Commercial Services

Technology Services

  1. Beurs
  2. Insiders
  3. Richard D. Gill
DE LAATSTE UREN | -40 %: De beste tools voorbehouden aan abonnees om de beste beleggingen van morgen te identificeren!
d
:
:
PROFITEER NU